What's The BUZZ?

Market News, Products, Services, and Trends

Medterra Launches New Clinical Line March 1st

Medterra’s new clinical line is exclusive to independent pharmacies and medical practices. This line will not be sold in any other stores and will not be offered on any e-commerce platform.


Medterra’s clinical line consists of stronger topical products and a new advanced cannabinoid blend. Many of you are familiar with full spectrum products consisting of other cannabinoids such as CBG, CBN, and CBC. Their new advanced cannabinoid blend consists of CBD, CBG, CBN, and CBC while still offering Zero THC. The concentrations of the minor cannabinoids are higher than any full-spectrum products currently in the market. They were able to isolate these cannabinoids and blend into one formula offering far higher concentrations.


 Why is this important to offer in your pharmacy? The clinical line offers superior products at a much more competitive price than the brands you currently carry. If your CBD sales have plateaued this is the perfect opportunity to offer new exciting products your patients will want to purchase.



Please contact Medterra for more information: Pharmacy@medterracbd.com

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

This post is related to:

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from Medterra Launches New Clinical Line March 1st

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe